TNFSF13 Antikörper (AA 21-120)
Kurzübersicht für TNFSF13 Antikörper (AA 21-120) (ABIN713816)
Target
Alle TNFSF13 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 21-120
-
Kreuzreaktivität
- Human
-
Homologie
- Mouse,Rat
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human TNFSF13
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))
-
Andere Bezeichnung
- TNFSF13
-
Hintergrund
-
Synonyms: A proliferation inducing ligand, A proliferation-inducing ligand, APRIL, CD 256, CD256, CD256 antigen, Ligand, proliferation inducing ligand APRIL, TALL 2, TALL-2, TALL2, TNF and APOL related leukocyte expressed ligand 2, TNF related death ligand 1, TNF related death ligand, TNF- and APOL-related leukocyte expressed ligand 2, TNF-related death ligand 1, TNF13_HUMAN, TNFSF 13, TNFSF13, TNFSF13 protein, TRDL 1, TRDL-1, TRDL1, Tumor necrosis factor ligand superfamily member 13, Tumor necrosis factor ligand superfamily member 13, Tumor necrosis factor related death ligand, Tumor necrosis factor related death ligand 1, Tumor necrosis factor superfamily member 13, TWE PRIL, ZTNF2.
Background: Cytokine that binds to TNFRSF13B/TACI and to TNFRSF17/BCMA. May be implicated in the regulation of tumor cell growth. May be involved in monocyte/macrophage-mediated immunological processes.
-
Gen-ID
- 8741
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
Target
-